Supplemental Figure 14 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Year: 2026
Type: supplementary-materials
Abstract: (A)On-treatment NLR in Excellent vs Non-Excellent Responders (Wilcoxon Rank-Sum Test).
Authors: Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi, Madelena Brancati, James M. Leatherman, Luke X. Zhao, Waqar Arif, Royce P. Lee, Jeric Hernandez, Nicole E. Gross, Caroline Ellis, Christopher Thoburn, Yasser Ged, Jeannie Hoffman-Censits, Evan J. Lipson, Marina Baretti, G. Scott Chandler, Rajat Mohindra, Laura Tang, Sanjay Bansal, Aditi Guha, Elizabeth M. Jaffee, Daniel J. Zabransky, Won J. Ho, Mark Yarchoan, Mari Nakazawa
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7205017987
Cites:
Cited by:
Related to: